AMRX — Amneal Pharmaceuticals, Inc.
7 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about AMRX (2026-11-03)
- Amneal Pharmaceuticals reported Q3 2026 financial results, achieving net revenue of $863 million, a 10% increase.
- The company raised its 2026 full-year revenue guidance to a range of $3.15 billion to $3.25 billion.
| Bluesky | 3 | community |
| GDELT | 2 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |